HALB - Halberd Corporation Creates Subsidiary to Use Its Patented Technology to Treat Cancer (Halb)

Halberd Corporation (OTC PINK: HALB), after recognizing the depth of application of its recently patented extracorporeal treatment approach, has announced the creation of a new subsidiary. The subsidiary comprises a group of researchers focusing on cancer treatment. The technology invented by Halberd can be applied to treat different diseases. Hence, the company’s management has decided not to waste time on developing potential cancer treatments.

Halberd’s existing technical team members will lead the subgroup. However, the team is expected to add the necessary expertise to achieve the corporation’s goal without diluting its current efforts toward reducing neurodegenerative ...